Site Menu


Building exclusive sales and marketing alliances

Strategic partnerships are at the core of Aprecia's plan to grow. Like us, our partners are dedicated to enhancing their customers' experiences.

Both our model and our culture align with our business relationships, which first started through exclusive licensing of the pharmaceutical applications of the Massachusetts Institute of Technology’s (MIT) three-dimensional printing (3DP) process. After successfully negotiating FDA approval of SPRITAM (levetiracetam) Tablet(s) for Oral Suspension, the first prescription drug product that is manufactured using the 3DP and ZipDose® Technology, we remain committed to bringing our proprietary ZipDose® Technology to the market in partnership with like-minded innovators. Learn more about the ways Aprecia forms strategic partnerships by exploring the pages below:


Our Parent Company

Prasco Laboratories, the Authorized Generics Company, is a privately held healthcare company located in Mason, Ohio. As the acknowledged category leader, Prasco has more Authorized Generic partnerships than any other company. Established brand companies rely on Prasco to bring their branded products to the generic marketplace as Authorized Generics, which offers alternatives to consumers and pharmacists. Through its investment in Aprecia Pharmaceuticals, Prasco adds even further depth to its offering across the pharmaceutical value chain for its brand pharma partners.

For more information, visit

If you are interested in partnership opportunities with Aprecia, please contact us.